StockData
Vistagen Therapeutics, Inc. logo

Vistagen Therapeutics, Inc. (VTGN) stock

VTGNNasdaqPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 9/3078% below fair value
$0.19+0.00 (+2.01%)

Close on Nov 17, 2026Market cap $8.34MP/E –Yield –

Vistagen Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Vistagen Therapeutics's market cap was $7.67M on Nov 11, 2026, against $159.19M a year earlier. Over the last 5 years it ranged from $6.87M to $297.50M, with a median of $53.45M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$7.67M-64.3%
2025Dec 31, 2025$21.50M-75.9%
2024Dec 31, 2024$89.34M+121.2%
2023Dec 29, 2023$40.40M+96.5%
2022Dec 30, 2022$20.56M-93.1%
2021Dec 31, 2021$297.50M+194.0%
2020Dec 31, 2020$101.21M+288.5%
2019Dec 31, 2019$26.05M-18.8%
2018Dec 31, 2018$32.10M+222.1%
2017Dec 29, 2017$9.97M+51.1%
2016Dec 30, 2016$6.60M-49.2%
2015Dec 31, 2015$12.98M+38.9%
2014Dec 31, 2014$9.34M+8.1%
2013Dec 31, 2013$8.64M-28.8%
2012Dec 31, 2012$12.14M-73.9%
2011Dec 30, 2011$46.49M–

More Vistagen Therapeutics figures

See a number that looks wrong?